Le Lézard
Classified in: Health, Covid-19 virus

BrainScope Completes Agreement with 18,000 Member Yankee Alliance

BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- BrainScope today announced a new system-wide agreement with Yankee Alliance to make BrainScope's innovative point-of-care neuro-technology system available to the 18,000 members, including over 5,000 outpatient facilities and senior centers, in Yankee Alliance. BrainScope is the only FDA cleared medical device that aids in the objective triage of head injured patients for suspected mild traumatic brain injuries (mTBIs), including brain bleed and concussion. When used by Emergency Departments (ED) in triage, BrainScope has demonstrated the potential to reduce the use of head CAT Scans by more than 30% while also improving the objective detection of concussion. With BrainScope, many patients can be spared unnecessary radiation from head CT while also benefiting from significantly faster wait times. Hospital EDs could see benefits from reduced patient length of stays, improved clinical workflows, and overall productivity improvements.

BrainScope advances commercialization with new Yankee Alliance 18,000-member agreement

"Our agreement with Yankee Alliance strengthens our ability to deploy our game changing mTBI detection technology to emergency departments across the country," said Susan Hertzberg Chief Executive Officer at BrainScope. "In the ED, where millions of head injured patients first seek care each year, BrainScope is the only system that aids in the full spectrum assessment of mild traumatic brain injuries including brain bleeds and concussion. The assessment uses EEG derived algorithms so there is no blood draw or processing in a lab?it is truly point-of-care and takes just minutes from patient prep to results. For newly concussed patients, it provides clinicians with actionable, objective insights that can inform patient treatment and management."  

The company's disposable headset connects to its handheld device which acquires, processes and analyzes thousands of brain activity-based physiological parameters, transforming them into structural and functional indices by using artificial intelligence derived algorithms. The results are immediately available on the device.

"Yankee Alliance continues to look for new partners, to bring value to our membership," said Amy Campbell, Chief Administrative Officer at Yankee Alliance. "As we continue to deal with the challenges COVID-19 and its variants have imposed on our members, it is all the more important for Yankee Alliance to help them lower cost of care, improve efficiencies in operations, and address the changing healthcare landscape. We are thrilled to be entering this partnership with BrainScope to provide our members with a rapid, easy-to-use device to assess mild traumatic brain injuries. We believe the BrainScope platform will not only give our members a highly-effective decision support tool, but will also increase patient safety and satisfaction while improving efficiency and effectiveness in dealing with head injuries."

About BrainScope
BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. BrainScope is leading the way in the rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), utilizing multiple integrated assessment capabilities, artificial intelligence (AI), and digitization. The company's technology supports the American College of Emergency Physicians (ACEP) Choosing Wisely® campaign to avoid CT scans of the head in emergency department patients with minor head injury. BrainScope's innovative neurotechnology platform uses EEG-based, AI-derived algorithms empowering physicians to quickly make accurate head injury assessments, addressing the full spectrum of traumatic brain injuries from structural (brain bleed) to functional (concussion) injuries, providing for the first time a full picture of the injury, and doing so in less time and without radiation. For more information, please visit www.brainscope.com.

About Yankee Alliance
Yankee Alliance is a member-driven healthcare group purchasing organization founded in 1984 on a belief in collaboration, that working together can achieve more than working alone. Our mission is twofold: to work with members to reduce supply and operating expenses through aggregation of data, purchasing, ideas and knowledge and to excel in strategic innovations that continually assist members in reducing their cost while recognizing their individual needs. Today, Yankee Alliance remains true to the foundational belief in collaboration and has grown to over 18,000 members in all classes of trades across all 50 states. For more information visit www.yankeealliance.com.

SOURCE BrainScope

These press releases may also interest you

at 07:45
The "Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global pharmerging market exhibited strong growth during 2015-2020. Looking...

at 07:43
CannabCo Pharmaceutical Corp. (CannabCo), a Canadian company located in Brampton, Ontario, is pleased to announce a milestone achievement with the testing of one of the industry's most potent cannabis strains at 41% total quantifiable cannabinoid...

at 07:35
Installed Building Products, Inc. (the "Company") , an industry-leading installer of insulation and complementary building products, announced today that the Company is seeking to raise a new 7-year $500 million Term Loan (the "New Term Loan") due...

at 07:35
Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeuticstm", today announced that the U.S. Food and Drug Administration ("FDA") has authorized an investigator-initiated...

at 07:35
Berry Global Group, Inc. today issued the following statement regarding the letter publicly released by Ancora Holdings Group LLC ("Ancora"): Berry Global's Board of Directors and management team are committed to acting in the best interest of the...

at 07:35
Eat Well Investment Group Inc. (the "Company" or "Eat Well Group" or "EWG") (CN:EWG) (US:EWGFF) (FRA:6BC0) is pleased to announce that it's majority-owned subsidiary, Amara Organic Foods ("Amara"), one of the fastest-growing baby food brands in...

News published on 19 october 2021 at 08:18 and distributed by: